Pharming Group Statistics

Total Valuation

Pharming Group has a market cap or net worth of $577.28 million. The enterprise value is $539.41 million.

Market Cap	577.28M
Enterprise Value	539.41M

Important Dates

The next confirmed earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharming Group has 67.84 million shares outstanding. The number of shares has increased by 2.24% in one year.

Shares Outstanding	67.84M
Shares Change (YoY)	+2.24%
Shares Change (QoQ)	+1.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.08%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	169.49
PS Ratio	2.06
Forward PS	2.45
PB Ratio	2.57
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.92
EV / EBITDA	65.35
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.81.

Current Ratio	1.43
Quick Ratio	1.16
Debt / Equity	0.81
Debt / EBITDA	22.06
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -5.20% and return on invested capital (ROIC) is -2.15%.

Return on Equity (ROE)	-5.20%
Return on Assets (ROA)	-2.40%
Return on Capital (ROIC)	-2.15%
Revenue Per Employee	$735,150
Profits Per Employee	-$30,697
Employee Count	382
Asset Turnover	0.58
Inventory Turnover	0.57

Taxes

Income Tax	-1.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.06% in the last 52 weeks. The beta is 0.80, so Pharming Group's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	-28.06%
50-Day Moving Average	8.69
200-Day Moving Average	10.72
Relative Strength Index (RSI)	50.13
Average Volume (20 Days)	3,429

Short Selling Information

Short Interest	2,921
Short Previous Month	8,002
Short % of Shares Out	0.00%
Short % of Float	n/a
Short Ratio (days to cover)	1.15

Income Statement

In the last 12 months, Pharming Group had revenue of $280.83 million and -$11.73 million in losses. Loss per share was -$0.20.

Revenue	280.83M
Gross Profit	249.26M
Operating Income	-8.75M
Pretax Income	-13.03M
Net Income	-11.73M
EBITDA	8.25M
EBIT	-13.03M
Loss Per Share	-$0.20

Full Income Statement

Balance Sheet

The company has $220.00 million in cash and $182.13 million in debt, giving a net cash position of $37.87 million or $0.56 per share.

Cash & Cash Equivalents	220.00M
Total Debt	182.13M
Net Cash	37.87M
Net Cash Per Share	$0.56
Equity (Book Value)	224.33M
Book Value Per Share	3.31
Working Capital	97.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.36 million and capital expenditures -$1.42 million, giving a free cash flow of -$3.78 million.

Operating Cash Flow	-2.36M
Capital Expenditures	-1.42M
Free Cash Flow	-3.78M
FCF Per Share	-$0.06

Full Cash Flow Statement

Margins

Gross margin is 88.76%, with operating and profit margins of -3.12% and -4.18%.

Gross Margin	88.76%
Operating Margin	-3.12%
Pretax Margin	-4.64%
Profit Margin	-4.18%
EBITDA Margin	2.94%
EBIT Margin	-4.64%
FCF Margin	-1.34%

Dividends & Yields

Pharming Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.24%
Shareholder Yield	-2.24%
Earnings Yield	-2.03%
FCF Yield	-0.65%

Analyst Forecast

The average price target for Pharming Group is $37.00, which is 334.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.00
Price Target Difference	334.78%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	12.01%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharming Group has an Altman Z-Score of 1.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.21
Piotroski F-Score	4